DSE:AMBEEPHA

Ambee Pharmaceuticals PLC announcements

253 Dhaka Stock Exchange announcements for Ambee Pharmaceuticals PLC (AMBEEPHA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2010 (15).

  1. The Company has informed that the Board of Directors of the company has decided, among others, to carry out the revaluat

    The Company has informed that the Board of Directors of the company has decided, among others, to carry out the revaluation of fixed assets (comprising thereon the Land, Factory Building, Plant and Capital Machinery) of the company, by appointing an assets revaluation company.

  2. In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Com

    In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.

  3. (Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2010 (July'10 to Sep'10), the com

    (Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2010 (July'10 to Sep'10), the company has reported net profit after tax of Tk. 2.44 million with EPS of Tk. 1.22 as against Tk. 3.13 million and Tk. 1.57 respectively for the same period of the previous year. Whereas net profit after tax was Tk. 4.16 million with EPS of Tk. 2.08 for the period of nine months (Jan'10 to Sep'10) ended on 30.09.10 as against Tk. 4.71 million and Tk. 2.35 respectively for the same period of the previous year.

  4. In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the com

    In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike.

  5. In view of recent abnormal price hike of shares of Ambee Pharmaceuticals Ltd., DSE has decided to investigate into the m

    In view of recent abnormal price hike of shares of Ambee Pharmaceuticals Ltd., DSE has decided to investigate into the matters. It is to be noted that DSE has already sent a query letter to the company regarding unusual price hike of shares.

  6. In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the com

    In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike.

  7. As per un-audited half yearly accounts as on 30.06.10 (Jan' 10 to June' 10), the company has reported net profit after t

    As per un-audited half yearly accounts as on 30.06.10 (Jan' 10 to June' 10), the company has reported net profit after tax of Tk. 1.72 million with EPS of Tk. 0.86 as against Tk. 1.58 million and Tk. 0.79 respectively for the same period of the previous year.

  8. Normal trading of the shares of the company will resume on 19.05.10 after record date.

    Normal trading of the shares of the company will resume on 19.05.10 after record date.

  9. Trading of the shares of the company will remain suspended on record date i.e. 18.05.10.

    Trading of the shares of the company will remain suspended on record date i.e. 18.05.10.

  10. As per un-audited quarterly accounts for the 1st quarter ended on 31st March 2010 (Jan'10 to Mar'10), the company has re

    As per un-audited quarterly accounts for the 1st quarter ended on 31st March 2010 (Jan'10 to Mar'10), the company has reported net profit after tax of Tk. 1.09 million with EPS of Tk. 0.55 as against Tk. 1.53 million and Tk. 0.76 respectively for the same period of the previous year.

  11. Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be

    Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 13.05.10 to 17.05.10. Trading of the shares of the company will remain suspended on record date i.e. 18.05.10.

  12. The company has further informed that the Record date for holding AGM of the company will be on 18.05.10 instead of 25.0

    The company has further informed that the Record date for holding AGM of the company will be on 18.05.10 instead of 25.05.10 to comply with SEC Notification dated October 05, 2009. The company has also reported EPS of Tk. 3.45, Net Asset Value per share of Tk. 23.71, and Net Operating Cash flow per Share of Tk. 12.12 for the year ended on 31.12.09. Other information of the AGM as announced earlier.

  13. There will be no price limit on the trading of the shares of the company on 02.05.10 following its corporate declaration

    There will be no price limit on the trading of the shares of the company on 02.05.10 following its corporate declaration.

  14. The Board of Directors has recommended cash dividend @ 30% (i.e. Tk. 3.00 per share of Tk. 10.00 each) for the year 2009

    The Board of Directors has recommended cash dividend @ 30% (i.e. Tk. 3.00 per share of Tk. 10.00 each) for the year 2009. Date of AGM: 29.06.10, Time: 10:00 AM. Venue: House No. 1, Road No. 71, Gulshan Avenue-2, Dhaka-1212. Record date: 25.05.10.

  15. In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the com

    In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.